Ceftazidime-Avibactam as Salvage Treatment for Infections Due to Carbapenem-Resistant Klebsiella pneumoniae in Liver Transplantation Recipients

BACKGROUND: Ceftazidime-avibactam (CZA) has been approved in vitro activity against carbapenem-resistant K. pneumoniae (CRKP), but the experience for the treatment of CRKP in liver transplantation (LT) recipients was limited, and previous data on its efficacy in this setting are lacking. METHODS: LT...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fang, Zhong, Han, Yang, Tengjiao, Shen, Chuan, Deng, Yuxiao, Han, Longzhi, Chen, Xiaosong, Zhang, Haomin, Qian, Yongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710070/
https://www.ncbi.nlm.nih.gov/pubmed/34992387
http://dx.doi.org/10.2147/IDR.S342163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710070/
https://www.ncbi.nlm.nih.gov/pubmed/34992387
http://dx.doi.org/10.2147/IDR.S342163

Ejemplares similares